Dey, M. Et Al. 2023. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study.. Rheumatology (Oxford, England) , vol.62, no.5 .

Dey, M., Naveen, R., Nikiphorou, E., Sen, P., Saha, S., Lilleker, J. B., ... Agarwal, V.(2023). Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study.. Rheumatology (Oxford, England) , vol.62, no.5.

Dey, Mrinalini Et Al. "Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study.," Rheumatology (Oxford, England) , vol.62, no.5, 2023

Dey, Mrinalini Et Al. "Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study.." Rheumatology (Oxford, England) , vol.62, no.5, 2023

Dey, M. Et Al. (2023) . "Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study.." Rheumatology (Oxford, England) , vol.62, no.5.

@article{article, author={Mrinalini Dey Et Al. }, title={Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study.}, journal={Rheumatology (Oxford, England)}, year=2023}